ARRY: Summary for Array BioPharma Inc. - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, November 25, 2009, 9:50am EST - Canadian Markets close in 6 hours and 10 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Array BioPharma, Inc. (ARRY)

At 09:34 EST: 1.95 USD

0.02 (1.04%)

MORE ON ARRY

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Array BioPharma Inc. (NGM:ARRY) Delayed quote data

Last Trade:	1.95 USD
Trade Time:	9:34AM EST
Change:	0.02 (1.04%)
Prev Close:	1.93
Open:	1.95
Bid:	1.94 x 800
Ask:	1.95 x 200
1y Target Est:	5.66

Day's Range:	1.94 - 1.95
52wk Range:	1.68 - 4.68
Volume:	2,702
Avg Vol (3m):	399,459
Market Cap:	96.15M
P/E (ttm):	N/A
EPS (ttm):	-2.48
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y max

Add ARRY to Portfolio

Download Data

HEADLINES

•	Array BioPharma to Present at the Piper Jaffray Healthcare Conference
	Business Wire (Mon, Nov 23)

•	ARRAY BIOPHARMA INC Financials
	EDGAR Online Financials (Fri, Nov 6)

•	HEADLINE STOCKS-U.S. small/midcap stocks on the move on Nov 5
	at Reuters (Thu, Nov 5)

•	Array Biopharma upgraded by UBS
	Briefing.com (Thu, Nov 5)

•	ARRAY BIOPHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal
	EDGAR Online (Tue, Nov 3)

•	Array BioPharma Inc. F1Q10 (Quarter Ended June 30, 2010) Earnings Call Transcript
	at Seeking Alpha (Tue, Nov 3)

•	Array BioPharma Inc. Earnings Call scheduled for 9:00 am ET today
	CCBN (Tue, Nov 3)

•	ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
	EDGAR Online (Mon, Nov 2)

•	Array BioPharma Reports Financial Results for the First Quarter of Fiscal 2010
	Business Wire (Mon, Nov 2)

•	Q1 2010 Array BioPharma Inc. Earnings Release - After Market Close
	CCBN (Mon, Nov 2)

More Headlines for ARRY...

ANALYST

EPS Est (next year) (Jun-10) :	-2.00
EPS Est (in 2 years) (Jun-11) :	-1.79
Avg Rec (current)*:	2.1
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Array BioPharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs to treat patients with cancer, inflammatory, and metabolic diseases in North America, Europe, and Asia Pacific.

Full Company Profile

Add to Portfolio

Email to a Friend

•